Watch CBS News

Gene editing could be a game changer for patients with sickle cell disease

The FDA is set to decide Friday on a gene editing technique for patients with sickle cell disease. It would be the first use of CRISPR in the United States to treat a disease. CBS News' chief medical correspondent Dr. Jon LaPook has more.
View CBS News In
CBS News App Open
Chrome Safari Continue